About LungLife AI
LungLife AI is a cancer diagnostics company focused on transforming cancer diagnosis and management through the artificial intelligence (AI) enabled molecular analysis of cancer biomarkers in blood.
LungLife AI is focused upon lung cancer diagnostic solutions recognizing the need to substantially improve patient outcomes. The company's testing methodology is designed to deliver actionable information to clinicians via minimally invasive blood draw. Our tests span all stages of lung cancer, from an aid in diagnosis for patients with suspicious lung nodules as well as treatment stratification and monitoring in late-stage lung cancer.
LungLife AI was founded in 2008 and is based in Westlake Village (Los Angeles), California.